Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: Preparation and in vitro permeation study

BMC Dermatology

Volumn 1, Issue , 2001, Pages

  Pierre, Maria Bernadete R ^a   Tedesco, Antônio C ^a   Marchetti, Juliana M ^a   Bentley, M Vitória L B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; LIPOSOME; TOPICAL AGENT; LIPID;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DERMIS; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENCAPSULATION; EPIDERMIS; EVAPORATION; GEL FILTRATION CHROMATOGRAPHY; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; LIPID COMPOSITION; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTON CORRELATION SPECTROSCOPY; SKIN CANCER; SKIN PENETRATION; SKIN PERMEABILITY; STRATUM CORNEUM; ANIMAL; HAIRLESS MOUSE; METABOLISM; METHODOLOGY; PARTICLE SIZE; PHOTOCHEMOTHERAPY; SKIN; SKIN TUMOR; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; LIPIDS; LIPOSOMES; MALE; MICE; MICE, INBRED HRS; PARTICLE SIZE; PHOTOCHEMOTHERAPY; SKIN; SKIN NEOPLASMS;

EID: 2942588610     PISSN: 14715945     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-5945-1-5     Document Type: Article

References (23)

1. De Rosa FS, Bentley MVLB: Photodynamic therapy of skin cancers: sensitizers, clinical studies and future. Pharm. Res. 2000, 17:1447-1455
2. Fuchs J, Thiele J: The role of oxygen in cutaneous photodynamic therapy. Free Radical Biology & Medicine 1998, 24:835-847
3. Ackermann G, Abels C, Baumler W, Langer S, Landthaler M, Lang EW, Szeimies RM: Simulations on the selectivity of 5-aminolevulinic acid-induced fluorescence in vivo. J. Photochem. Photobiol. B: Biol. 1998, 47:121-128
4. Robinson DJ, Bruijn HS, Van Der Veen N, Stringer MR, Brown SB, Star WM: Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem. Photobiol. 1998, 67:140-149
5. Morton AC, Whitehurst C, Moseley H, Mccoll JH, Moore JV, Mackie R: Comparision of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br. J. Dermatology 1996, 135:766-771
6. De Rosa FS, Marchetti JM, Thomazini JA, Tedesco AC, Bentley MVLB: A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J.Control. Release 2000, 65:359-366
7. Malik Z, Kostenich L, Roitman B, Ehrenberg B, Orestein A: Topical appication of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J. Photochem. Photobiol.B: Biol 1995, 28:213-218
8. Kalka K, Merck H, Mukhtar H: Photodynamic therapy in dermatology. J. Am. Acad. Dermatol 2000, 42:389-413
9. Lopez RFV, Bentley MVLB, Delgado-Charro MB, Guy RH: Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Proceed. Int'l. Symp. Control. Rel. Bioact. Mater. 2000, 27:7407
10. MA L, Moan J, Peng Q, Iani V: Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human coloadenocarcinoma of nude mice ca be increased by ultrasound. Int. J. Cancer 1998, 78:464-469
11. Kloek J, Akkermans W, Van Henegouwen GMJB: Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzimatic conversion into protoporphyrin. Photochem. Photobiol. 1998, 67:150-154
12. Downing DT, Abraham W, Wegner BK, Willman KW, Marshall JL: Partition of dodecyl sulfate into stratum corneum lipid liposomes. Arch. Dermatol. Res. 1993, 285:151-157
13. Korting HC, Stolz W, Schmid MH, Maierhofer G: Interaction of liposomes with human epidermis reconstructed in vitro. Br. J. Dermatol 1995, 132:571-579
14. Wertz PW, Abraham W, Landmann L, Downing DT: Preparation of liposomes from stratum corneum lipids. J. Invest. Dermatol 1986, 87:582-584
15. Schmid MH, Korting HC: Therapeutic progress with topical liposome drugs for skin disease. Adv. Drug Deliv. Rev. 1996, 18:335-342
16. Szocka F, Papahadjopoulos D: Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. 1978, 75:4194-4198
17. Oishi H, Nomiyama H, Nomiyama K, Tomokuni K: Fluorometric HPLC determination of 5-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure. J. Anal. Toxicol. 1996, 20:106-110
18. Mitragotri S: In situ determination of partition and diffusion coefficients in the lipid bilayers of stratum corneum. Pharm. Res 2000, 17:1026-1029
19. Bentley MVLB, Kedor ERM, Vianna RF, Collet JH: The influence of lecithin and urea on the in vitro permeation of hydrocortisone acetate through skin from hairless mouse. Int. J. Pharm 1997, 146:255-262
20. Coderch L, De Pera M, Perez-Cullell N, Estelrich J, De La Maza, Parra JH: The effect of liposomes on skin barrier structure. Skin Pharmacol. Appl. Skin Physiol 1999, 12:235-246
21. Kirjavainen M, Urtti A, Jaaskelaine I, Suhonnen TM, Paronen P, Valjakka-Koskela R, Kiesvaaro J, Monkkonen J: Interaction of liposomes with human skin in vitro - the influence of lipid composition and structure . Biochim. Biophys. Acta 1996, 1304:179-189
22. Shah VP, Behl CR, Flynn GL, Higuchi WI, Schaefer H: Principles and criteria in the development and optimization of topical therapeutical products. Int. J. Pharm. 1992, 82:21-28
23. Hatziantoniou S, rallis S, Demetzos C, Papaionnou GT: Pharmacological activity of natural lipids on skin barrier disruption model. Pharmacol. Res 2000, 42:55-59